- Home
- CFBK vs CYBN Comparison
CFBK vs CYBN Comparison
Compare CFBK & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFBK
- CYBN
- Stock Information
- Founded
- CFBK 1892
- CYBN 2019
- Country
- CFBK United States
- CYBN Canada
- Employees
- CFBK N/A
- CYBN N/A
- Industry
- CFBK Major Banks
- CYBN Pharmaceuticals and Biotechnology
- Sector
- CFBK Finance
- CYBN Health Care
- Exchange
- CFBK Nasdaq
- CYBN Nasdaq
- Market Cap
- CFBK 154.9M
- CYBN 163.6M
- IPO Year
- CFBK 1998
- CYBN N/A
- Fundamental
- Price
- CFBK $24.14
- CYBN $8.96
- Analyst Decision
- CFBK Buy
- CYBN Strong Buy
- Analyst Count
- CFBK 1
- CYBN 4
- Target Price
- CFBK $29.00
- CYBN $86.00
- AVG Volume (30 Days)
- CFBK 36.5K
- CYBN 317.4K
- Earning Date
- CFBK 08-05-2025
- CYBN 08-07-2025
- Dividend Yield
- CFBK 1.15%
- CYBN N/A
- EPS Growth
- CFBK N/A
- CYBN N/A
- EPS
- CFBK 2.28
- CYBN N/A
- Revenue
- CFBK $47,663,000.00
- CYBN N/A
- Revenue This Year
- CFBK $35.39
- CYBN N/A
- Revenue Next Year
- CFBK $10.11
- CYBN N/A
- P/E Ratio
- CFBK $10.50
- CYBN N/A
- Revenue Growth
- CFBK 1.22
- CYBN N/A
- 52 Week Low
- CFBK $18.20
- CYBN $4.81
- 52 Week High
- CFBK $31.17
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- CFBK 60.31
- CYBN 65.58
- Support Level
- CFBK $23.30
- CYBN $7.11
- Resistance Level
- CFBK $24.07
- CYBN $8.70
- Average True Range (ATR)
- CFBK 0.36
- CYBN 0.57
- MACD
- CFBK 0.01
- CYBN 0.05
- Stochastic Oscillator
- CFBK 85.19
- CYBN 88.97
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.